The subject made modifications on diet, anabolic-androgenic
steroid administration, and exercise strategies dependent upon
body composition calculations. Precompetition pharmaceutical,
dietary, and body composition data is presented on table 3.
TABLE 3
|
Period |
Body Weight |
Percent Fat |
Fat Weight |
Lean Weight |
Ave Lean Gain |
Drugs |
Ave Dosage |
Calories |
Protein |
Carbs |
Fat |
|
lbs |
(7 Site) |
lbs |
lbs |
lbs/day |
code |
mg/day |
kcal |
g/day |
percent |
g/day |
percent |
g/day |
percent |
|
1 |
206.5 |
5.86 |
12.1 |
194.4 |
0.998 |
AD |
55.6 |
5721 |
278.4 |
19 |
742.2 |
51 |
191.7 |
30 |
|
2 |
216.0 |
5.86 |
12.7 |
203.0 |
0.207 |
AD, EQ |
60.7 |
6380 |
309.3 |
19 |
866.5 |
53 |
203.8 |
28 |
|
3 |
220.5 |
6.50 |
14.3 |
206.2 |
0.321 |
AD, EQ |
78.6 |
5990 |
309.1 |
20 |
823.5 |
54 |
177.6 |
26 |
|
4 |
225.0 |
6.34 |
14.3 |
210.7 |
0.066 |
TC, DC, WV |
65.0 |
5815 |
355.8 |
24 |
762.3 |
51 |
163.2 |
25 |
|
5 |
224.5 |
5.70 |
12.8 |
211.7 |
0.060 |
EQ |
108.3 |
7281 |
366.9 |
20 |
995.4 |
53 |
223.0 |
27 |
|
6 |
224.5 |
5.54 |
12.4 |
212.1 |
0.400 |
AD, H |
93.8 |
5699 |
359.5 |
25 |
808.6 |
56 |
127.0 |
20 |
|
7 |
227.5 |
5.38 |
12.2 |
215.3 |
0.500 |
AD |
178.6 |
6877 |
392.2 |
22 |
962.0 |
55 |
176.5 |
23 |
|
8 |
232.0 |
5.70 |
13.2 |
218.8 |
-0.188 |
AD |
162.5 |
5798 |
378.8 |
26 |
807.3 |
55 |
124.9 |
19 |
|
9 |
228.5 |
4.89 |
11.2 |
217.3 |
-0.433 |
H, WV |
61.6 |
6596 |
423.0 |
25 |
953.9 |
57 |
134.0 |
18 |
|
10 |
225.7 |
4.89 |
11.0 |
214.7 |
0.686 |
AD, PD, WV |
157.1 |
6525 |
381.3 |
23 |
941.9 |
58 |
137.2 |
19 |
|
11 |
230.0 |
4.56 |
10.5 |
219.5 |
-0.229 |
AD, WV |
150.0 |
6982 |
492.0 |
28 |
866.0 |
50 |
170.0 |
22 |
|
A 12 |
227.5 |
4.24 |
9.6 |
217.9 |
-0.229 |
None |
0.0 |
6475 |
397.0 |
24 |
867.0 |
53 |
165.0 |
23 |
|
13 |
226.5 |
4.40 |
10.0 |
216.5 |
-0.280 |
AD |
150.0 |
|
|
|
B |
230.0 |
|
adlib |
|
|
14 |
238.0 |
|
The subject consumed an estimated daily average of 5699-7281
kcalories throughout all periods. Throughout all periods the
percentage of calories from foodstuffs consisted of; protein:
19%-28%, carbohydrates: 51%-58%, fats: 19%-30%. Meals were usually
spaced approximately 2.5 to 3 hours apart.
Period 1
The greatest lean body weight gain was seen the first ten
days. The lean body mass gain of 8.9 lbs (0.988 lb / day) was
undoubtedly due to the introduction of drugs. Oxmetholone (Anadrol)
was used this period with an average administration of 55.6 mg
/ Daily for approximately 9 days.
Period 2
A substantially smaller gain in lean body weight was seen
the second period consisting of approximately 14 days. The gain
in lean body mass was only 2.9 lbs (0.207 lb / day). Beginning
two days preceding the period, an average of 62.5 mg of Oxmetholone
(Anadrol) was taken for four days. Also beginning the same time,
300 mg of Boldenone undecylenate (Equipoise) was administered
every week. An average daily dosage of 60.7 mg / daily was taken
with both drugs combined.
Period 3
The third period reflected an acceptable gain in lean body
mass when both Boldenone undecylenate (Equipoise) and Oxmetholone
(Anadrol) were administered at an average dosage of 78.6 mg /
daily. Beginning two days preceding the period, 300 mgs. of Boldenone
undecylenate (Equipoise) was administered every week and an average
of 35.7 mgs of Oxmetholone (Anadrol) was taken daily in descending
fashion ranging from 50 mg ­ 7.5 mg . In these 14 days, 4.5
lbs (.321 lbs / day) in lean body mass was seen.
Period 4
A gain of only 1 lb (.066 lb / day) in lean body mass was
seen the fourth period of 15 days. Three days preceding this
period, suspected counterfeit Testosterone cypionate (Depo-Testosterone)
and Nandrolone decanoate (Deca Durabolin) were administered.
According to the concentrations indicated on their labels, 600
mgs. of Testosterone cypionate (Depo-Testosterone) and 175 mg
of Nandrolone decanoate (Deca Durabolin) was administered. The
subject felt and saw no effect after the first week then proceeded
to administer 50 mgs of Stanozolol (Winstrol­V) every other
day until the end of the period. Despite the greater than average
dosage of Testosterone cypionate (Depo-Testosterone) the average
daily dosage of all drugs in that period was only 65 mg / day.
Period 5
The fifth period lasted only 6 days. Three days preceding
the period, 650 mgs of Boldenone undecylenate (Equipoise) was
administered over three days, since one syringe could only hold
3 cc, or 150 mgs. Only .4 lbs (.06 lbs / day) of lean body weight
was seen with 108.33 mg / day of Equipoise.
Period 6
The six period, lasting 8 days, yielded a larger gain of 3.2
lbs (.4 lbs / day) in lean body mass. One day preceding the period,
100 mgs of Oxmetholone (Anadrol) was taken all but one day in
which 50 mgs of Fluoxymesterone (Halotestin) was replaced out
of lack of a reliable supply. So, an average of 87.5 mgs / daily
of Oxmetholone (Anadrol) and an average of 6.25 mgs / daily of
Oxmetholone (Anadrol) were taken during this period for a total
of 93.75 / daily for both drugs.
Period 7
A greater dosage of Oxmetholone (Anadrol) was take the seventh
period lasted 7 days. Beginning three days preceding the period,
150 mg of Oxmetholone (Anadrol) was taken daily the first 2 days
proceeded by 200 mg of Oxmetholone (Anadrol) daily there after.
A gain of 3.5 lbs ( .5 lbs / day) of lean body mass was made
from an average daily dosage of 178.6 mgs of (Oxmetholone) Anadrol.
Period 8
The eighth period lasted 8 days. Two days preceding the period
an daily average of 162.5 mgs of Oxmetholone (Anadrol) was administered
daily in descending fashion for the full duration of the period.
A loss of 1.5 lbs (-.188 lbs / day) of lean body weight became
the result.
Period 9
A loss of lean body mass was also characteristic of the ninth
period lasting 6 days. The day of the period, an average of 54.2
mg of Stanozolol (Winstrol-V) was administered daily throughout
the period. Fluoxymesterone (Halotestin) was also taken the first
three days in descending fashion averaging only 15 mg for these
few days. The average daily dosage for both drugs was only 61.6
mgs. A total of 2.6 lbs (­.433 lbs / day) of lean body mass
was lost during this period. The dosage difference from the previous
week did not seem to be significantly reduced. Suspicion may
be placed on the characteristics of the descending drug program.
Period 10
The tenth period lasted 7 days. Beginning the day of the cycle
day, an average of 57.1 mg of Oxmetholone (Anadrol) and 57.1
mg of (Stanozolol) Winstrol-V were taken daily throughout the
period. Also beginning the same time, 50 mg of Primobolan Depot
was administered for 5 days. Methenolone enanthate (Primobolan
Depot) was taken daily in this manner out of convenience despite
its longer acting quality. An average daily dosage of 157.1 mg
of drugs were taken this period. As a result, 4.8 lbs (.686 lbs
/ day) of lean body mass was obtained.
Period 11
The eleventh period lasted 7 days. Beginning the day of the
period an average of 114.3 mg of Oxmetholone (Anadrol) was taken
daily. Also beginning the same time, 50 mg of Stanozolol (Winstrol­V)
was taken daily except for the second and third days of the period.
A daily average dosage of 150 mg was taken from both drugs. A
loss of 1.6 lbs (-.229 lbs) of lean body weight was the result.
No Drugs were taken after one day before the physique competition.
This was done because Anadrol taken preceding the show was thought
to contribute to subcutaneous water retention. No other drug
was taken due to convenience and the relatively small contribution
an administration was thought to have the day preceding the show.
Final Week
Since fat reduction was not as a great of a concern the last
week, the total caloric intake was increased slightly in attempt
to allow adequate calories for recovery and increased glycogen
stores. Resistive training was stopped four days before the show
in effort to restore glycogen in the muscle. Walking and posing
practice were continued. Posing with the aid of a mirror was
greatly reduced. Walking was used more as a means of stress management
than fat burning activity the final days before the show. Three
days before the show, an effort was made to reduce food volume
and maintain an elevated caloric intake by eating less more often
in order to reduce abdominal circumference caused by intestinal
volume. In addition, foods suspected of causing gas and minor
food allergies were eliminated. Foods containing added salt were
discontinued two days before the show in effort to deplete subcutaneous
water. Timing was crucial at this point since it was feared that
a premature sodium depletion would trigger negative feed back
from the bodies receptors resulting in a retention of sodium
by the body. Tap water was also replaced by distilled water two
days before the show to insure a reduced sodium intake. Posing
was increased two days before the show in effort to expel subcutaneous
water. Water intake was increased the day before the show in
attempt to inhibit Anti­diuretic Hormone produced in the
body. Approximately six ounces of beer was consumed the evening
before the show as to further inhibit Anti-diuretic hormone in
effort to deplete subcutaneous water.
Competition Day A
Water was consumed sparingly upon arising the morning of the
show to maintain the diuretic effects noted after slumber. A
suppository laxative was used the morning of the show in effort
to further reduce inter­intestinal volume. Water was consumed
as desired approximately an hour or so before the morning prejudging.
On the morning of the contest, a total body weight of 226 lbs
was recorded from a scale used for competition weigh in. Minor
cramping was experienced with virtually no effect upon posing
performance. Moderate sweating was noted on stage with little
hindrance on appearance. The subject won his weight class and
the overall competition, therefore qualifying for national competition.
Period 12
The twelfth period lasted seven days. The day of the period,
150 mg of Winstrol­V was administered. No other administrations
of Winstrol-V or any other drug was taken during this period
in anticipation of possible drug testing. The physique contest
discussed above was on the second day of this period. A loss
of 1.4 lbs (-.2 lbs / day) of lean body mass was noted at the
end of this period.
Period 13
Little data was recorded the thirteenth period which lasted
five days. Approximately the same dietary and exercise modifications
used before the last competition where practiced before the national
competition. Abstinence from anabolic-androgenic steroids was
continued throughout this period lasting up until four days prior
to national competition. Defend (Power Distributors, Marina Del
Rey, CA) was taken before drug testing as directed by the manufacturer.
A "weigh-in" and a "random drug test" was
scheduled three days prior to the event. The subject was not
selected for testing, but was measured at 230 lbs on the scale
used for official weigh in. On the same day, immediately after
"weigh-in", 300 mg of Oxmetholone (Anadrol) was consumed
through out the remainder of the day. The following day, 200
mg of Oxmetholone (Anadrol) was consumed followed by 150 mg the
next day.
Competition Day B
Finally, 50 mg of Oxmetholone (Anadrol) was take on the day
of the show. No body weight was taken on the actual day of the
show. Excessive sweating was experienced during prejudging which
negatively effected appearance.
Period 14
The subject broke his contest diet soon after the conclusion
of the final competition. A few days after the nationals, a body
weight of 238 lbs was reported.
|